J. R. Ciotti

Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.

Gregory F. Wu, A. Cross, R. Naismith, 2020, Multiple sclerosis and related disorders.

Disease-Modifying Treatment in Progressive Multiple Sclerosis

A. Cross, John R. Ciotti, J. R. Ciotti, 2018, Current Treatment Options in Neurology.

Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series

Y. Mao-Draayer, Amy Kunchok, S. Mariotto, 2022, Journal of Neuroimmunology.

Clinical instrument to retrospectively capture levels of EDSS.

A. Cross, A. Salter, J. Berger, 2019, Multiple sclerosis and related disorders.

Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica

Gregory F. Wu, A. Cross, M. Brier, 2021, Multiple sclerosis.

Effects of MS disease-modifying therapies on responses to vaccinations: A review.

A. Cross, M. Valtcheva, John R. Ciotti, 2020, Multiple Sclerosis and Related Disorders.

Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD.

Gregory F. Wu, D. Yablonskiy, A. Cross, 2023, Multiple Sclerosis and Related Disorders.

Perspectives and experiences with COVID-19 vaccines in people with MS

Jeffrey A. Cohen, E. Mowry, D. Perantie, 2022, Multiple sclerosis journal - experimental, translational and clinical.